Use UniProt P18090 as the stable identity anchor, then attach disease evidence before program review.
CHEMBL2095166 Target Snapshot
Adrenergic receptor beta · PROTEIN FAMILY · Rattus norvegicus
Research home keeps recent targets
This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.
Switch target
Move to another high-traffic target or paste a specific ChEMBL target ID.
Frame the target before identity details
Structured disease, protein, and project context should read before the lower-level identity rail.
As of 2026-09-14Protein identity stays anchored to UniProt P18090. Use UniProt P18090 as the stable identity anchor, then attach disease evidence before program review.
Beta-1 adrenergic receptor
Review this target as Adrenergic receptor beta, mapped to UniProt P18090. ChEMBL maps the protein component as Beta-1 adrenergic receptor. Sequence length is 466 aa.
Protein source · UniProt accession via ChEMBL component mappingCross-source identity
Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats Adrenergic receptor beta as ChEMBL target CHEMBL2095166, mapped to UniProt P18090. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Start with the right source
Choose the first block or source based on the question you are trying to answer.
Start here when your first question is whether Adrenergic receptor beta is the right protein anchor across sources, using UniProt P18090 as the stable mapping.
Jump to Protein ContextUse this block first when you need the strongest disease program and evidence level in one place.
Jump to Disease ContextOpen the one-page evidence card when you want the rationale, activity base, and attribution together.
Open Review-ready CardBasic Information
Verify identity, organism, and the fastest next research jumps from the same page.
| Preferred Name | Adrenergic receptor beta |
| Target Type | PROTEIN FAMILY |
| Organism | Rattus norvegicus |
| UniProt | P18090 |
Next Actions
UniProt Target Context
Reviewable protein naming and mapping context for this target snapshot.
| Protein Label | Beta-1 adrenergic receptor |
| UniProt Accession | P18090 |
| Component Type | Protein |
| Sequence Length | 466 aa |
Beta-1 adrenergic receptor
How to read this target
Review this target as Adrenergic receptor beta, mapped to UniProt P18090. ChEMBL maps the protein component as Beta-1 adrenergic receptor. Sequence length is 466 aa.
Clinical Phase Distribution
Activity Type Distribution
Top Inhibitors (by pChEMBL)
| ChEMBL ID | pChEMBL | Type | Value (nM) | Phase |
|---|---|---|---|---|
| CHEMBL157881 | 9.34 | Ki | 0.46 | Preclinical |
| CHEMBL348176 | 9.21 | Ki | 0.61 | Preclinical |
| CHEMBL452861 | 9.15 | Kd | 0.7 | Clinical |
| CHEMBL543099 | 9.05 | IC50 | 0.9 | Preclinical |
| CHEMBL348176 | 9.0 | Kd | 1.0 | Preclinical |
| CHEMBL553039 | 8.96 | IC50 | 1.09 | Preclinical |
| CHEMBL156754 | 8.92 | Kd | 1.2 | Preclinical |
| CHEMBL46136 | 8.89 | Kd | 1.3 | Preclinical |
| CHEMBL156628 | 8.85 | Kd | 1.4 | Preclinical |
| CHEMBL157881 | 8.8 | Kd | 1.6 | Preclinical |
pChEMBL Value Distribution
Approved Drugs
Assay Landscape
Binding — 120 assays, 103 compounds
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| assay format | 56 | 40 | 7.7 |
| protein format | 32 | 18 | 6.9 |
| tissue-based format | 16 | 10 | 5.6 |
| cell membrane format | 13 | 24 | 6.4 |
| cell-based format | 3 | 11 | 7.0 |
Functional — 38 assays, 25 compounds
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| assay format | 16 | 9 | 7.1 |
| organism-based format | 9 | 0 | — |
| tissue-based format | 7 | 9 | 6.6 |
| cell-based format | 6 | 7 | 7.4 |
ADME — 1 assays, 0 compounds
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| assay format | 1 | 0 | — |